|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 NGN | 0.00% |
|
-8.11% | -12.37% |
Neimeth International Pharmaceuticals Plc reported earnings results for the fifteen months ended December 31, 2022. For the fifteen months, the company reported sales was NGN 3,649.15 million. Net loss was NGN 289.97 million.
Basic loss per share from continuing operations was NGN 0.15.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.37% | 4.95M | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 
